A dose-finding study of a MUC-1 vaccine in conjunction with poly-IC:LC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxy methylcellulose) in immunosuppressed (IS) patients (pts) with advanced prostate cancer (PCa).
A. K. Patel
No relevant relationships to disclose
L. J. Appleman
No relevant relationships to disclose
W. E. Gooding
No relevant relationships to disclose
D. Friedland
No relevant relationships to disclose
J. McKolanis
No relevant relationships to disclose
A. M. Salazar
Employment or Leadership Position - Oncovir
Stock Ownership - Oncovir
O. J. Finn
No relevant relationships to disclose
G. S. Chatta
No relevant relationships to disclose